AbbVie (ABBV) Debt Ratio (2012 - 2026)
AbbVie (ABBV) posted quarterly Debt Ratio of 0.47 for Q1 2026, down 5.72% YoY from 0.5 in Q1 2025, and up 3.11% sequentially from 0.46 in Q4 2025.
AbbVie (ABBV) Debt Ratio (2012 - 2026) Analysis & Trends
AbbVie has disclosed Debt Ratio across 15 years of filings, most recently posting 0.47 for Q1 2026.
- In Q1 2026, Debt Ratio fell 5.72% year-over-year to 0.47; the TTM figure through Mar 2026 stood at 0.47 (down 5.72% YoY), while the FY2025 annual figure was 0.46, down 7.67% from the prior year.
- Debt Ratio grew to 0.47 in Q1 2026, from 0.46 in the prior quarter.
- Over the last five years, Debt Ratio for ABBV reached as high as 0.51 in Q2 2022 and fell as low as 0.41 in Q2 2023.
- The 5-year median for Debt Ratio is 0.46 (2023), against an average of 0.47.
- Annual changes were most pronounced in 2022 — Debt Ratio dropped 21.93% — and 2024, when it climbed 20.7%.
- A 5-year view of Debt Ratio shows it stood at 0.46 in 2022, then decreased by 3.29% to 0.44 in 2023, then advanced by 12.69% to 0.5 in 2024, then slipped by 7.67% to 0.46 in 2025, then rose by 3.11% to 0.47 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.47, 0.46, and 0.49 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.37 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.27 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.47 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -0.21 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.38 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.62 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.39 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.31 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.46 |
| Sep 30, 2025 | 0.49 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.50 |
| Dec 31, 2024 | 0.50 |
| Sep 30, 2024 | 0.50 |
| Jun 30, 2024 | 0.50 |
| Mar 31, 2024 | 0.43 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.45 |
| Jun 30, 2023 | 0.41 |
| Mar 31, 2023 | 0.46 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.51 |
| Mar 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.52 |
| Sep 30, 2021 | 0.54 |
| Jun 30, 2021 | 0.55 |